Molecular Responses to Hypoxia-Inducible Factor 1α and Beyond

被引:105
作者
Brocato, Jason [1 ]
Chervona, Yana [1 ]
Costa, Max [1 ]
机构
[1] NYU, Langone Med Ctr, Dept Environm Med, New York, NY 10016 USA
基金
美国国家卫生研究院;
关键词
RENAL-CELL-CARCINOMA; FACTOR-I; FACTOR (HIF)-1-ALPHA; PYRUVATE-KINASE; CANCER-CELLS; FACTOR-1-ALPHA EXPRESSION; THERAPEUTIC IMPLICATIONS; PROGNOSTIC-SIGNIFICANCE; UNFAVORABLE PROGNOSIS; HISTONE DEMETHYLASES;
D O I
10.1124/mol.113.089623
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cellular response to changes in oxygen tension during normal development or pathologic processes is, in part, regulated by hypoxia-inducible factor (HIF), an oxygen-sensitive transcription factor. HIF activity is primarily controlled through post-translational modifications and stabilization of HIF-1 alpha and HIF-2 alpha proteins and is regulated by a number of cellular pathways involving both oxygen-dependent and -independent mechanisms. Stabilization of HIF-1 alpha activates transcription of genes that participate in key pathways in carcinogenesis, such as angiogenesis, dedifferentiation, and invasion. Since its discovery more than two decades ago, HIF-1 alpha has become a hot topic in molecular research and has been implicated not only in disease pathology but also in prognosis. In this review, we will focus on recent insights into HIF-1 alpha regulation, function, and gene expression. We will also discuss emerging data on the involvement of HIF in cancer prognosis and therapeutic interventions.
引用
收藏
页码:651 / 657
页数:7
相关论文
共 80 条
  • [1] Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/AKT/mTOR Pathway in Cancer
    Agani, Faton
    Jiang, Bing-Hua
    [J]. CURRENT CANCER DRUG TARGETS, 2013, 13 (03) : 245 - 251
  • [2] An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia
    Benita, Yair
    Kikuchi, Hirotoshi
    Smith, Andrew D.
    Zhang, Michael Q.
    Chung, Daniel C.
    Xavier, Ramnik J.
    [J]. NUCLEIC ACIDS RESEARCH, 2009, 37 (14) : 4587 - 4602
  • [3] Birner P, 2000, CANCER RES, V60, P4693
  • [4] Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications
    Cao, Dan
    Hou, Mei
    Guan, Yong-song
    Jiang, Ming
    Yang, Yu
    Gou, Hong-feng
    [J]. BMC CANCER, 2009, 9
  • [5] Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma
    Chai, Da-min
    Bao, Zheng-qi
    Hu, Jian-guo
    Ma, Li
    Feng, Zhen-zhong
    Tao, Yi-sheng
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (03) : 385 - 391
  • [6] Iron- and 2-oxoglutarate-dependent Dioxygenases: an emerging group of molecular targets for nickel toxicity and carcinogenicity
    Chen, Haobin
    Costa, Max
    [J]. BIOMETALS, 2009, 22 (01) : 191 - 196
  • [7] Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells
    Chen, Meng-Chuan
    Lee, Chi-Feng
    Huang, Wen-Hsin
    Chou, Tz-Chong
    [J]. BIOCHEMICAL PHARMACOLOGY, 2013, 85 (09) : 1278 - 1287
  • [8] The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
    Christofk, Heather R.
    Vander Heiden, Matthew G.
    Harris, Marian H.
    Ramanathan, Arvind
    Gerszten, Robert E.
    Wei, Ru
    Fleming, Mark D.
    Schreiber, Stuart L.
    Cantley, Lewis C.
    [J]. NATURE, 2008, 452 (7184) : 230 - U74
  • [9] Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study
    Daponte, Alexandros
    Ioannou, Maria
    Mylonis, Ilias
    Simos, George
    Minas, Marcos
    Messinis, Ioannis E.
    Koukoulis, George
    [J]. BMC CANCER, 2008, 8 (1)
  • [10] The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-α
    Dayan, F
    Roux, D
    Brahimi-Horn, MC
    Pouyssegur, J
    Mazure, NM
    [J]. CANCER RESEARCH, 2006, 66 (07) : 3688 - 3698